BCA
MRTX

Berman Capital Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Berman Capital Advisors’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		$34K Buy
196
+90
+85% +$15.6K 0.01% 827
2021
Q2 		$17K Buy
106
+34
+47% +$5.45K ﹤0.01% 979
2021
Q1 		$12K Buy
+72
New +$12K ﹤0.01% 986